Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
Molecular Cancer Research : MCR|September 28, 2018
Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of <i>BRCA1</i> BRCT Variants on Cancer RiskAmbre Petitalot, Elodie Dardillac, Eric Jacquet, et al.Oncotarget|June 23, 2016
Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomasMarie-Paule Sablin, Coraline Dubot, Jerzy Klijanienko, et al.Genes|December 23, 2022
The Identification of Large Rearrangements Involving Intron 2 of the <i>CDH1</i> Gene in <i>BRCA1/2</i> Negative and Breast Cancer SusceptibilityJihenne Ben Aissa-Haj, Hugo Pinheiro, François Cornelis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancerMagali Olivier, Anita Langerød, Patrizia Carrieri, et al.Journal of the National Cancer Institute|September 7, 2006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancerMarc Buyse, Sherene Loi, Laura van't Veer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation seriesChristine Desmedt, Fanny Piette, Sherene Loi, et al.Genome Medicine|March 16, 2021
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter studyCéline Callens, Keltouma Driouch, Anaïs Boulai, et al.Cancer Research|September 19, 2007
Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancerJeroen T Buijs, Nico V Henriquez, Petra G M van Overveld, et al.Nature Medicine|September 22, 2009
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumorsFrançois Ghiringhelli, Lionel Apetoh, Antoine Tesniere, et al.Breast Cancer Research : BCR|July 6, 2012
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.Pageof 12